Effects of Kegel Exercises and Myokinetic Release of Trigger Points in Primary Dysmenorrhea

Effects of Kegel Exercises With and Without Myokinetic Active Release of Trigger Points on Pain, Fatigue and Quality of Life in Primary Dysmenorrhea

The rationale of this study is despite the widespread belief that exercise can reduce dysmenorrhea, evidence-based studies are limited. Studies are therefore required to evaluate the association between quality of life and the primary dysmenorrheal females, the functional impact on the quality of life and primary dysmenorrhea females also it's a crucial time for females to focus on their studies and dysmenorrhea can add to the fatigue levels and cause distress in this age group thus the purpose of this study is to determine whether myokinetic active release of trigger points in the rectus abdominis, gluteus medius and quadratus lumborum is a more effective way to reduce dysmenorrhea than kegel exercises

Study Overview

• Status: Recruiting
• Conditions: Primary Dysmenorrhea
• Intervention / Treatment: Other: Kegel exercises

Detailed Description

Existing research may concentrate on specific interventions or populations, leaving a void in our knowledge of the possible synergistic effects of various exercises when done both alone and in combination, Studies have provided that dysmenorrhea is treated with pelvic floor strengthening however, there is little evidence that myokinetic involvement can lead to progressive outcomes. Given the interdependence of physiology, anatomy and dysfunction. Myokinetic trigger point release may be helpful in promoting the recovery of primary dysmenorrhea.

• Study Type: Interventional
• Enrollment (Estimated): 50
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: imran NA amjad, phd; Phone Number: 03324390125; Email: imran.amjad@riphah.edu.pk

Study Locations

• Pakistan
  • Punjab
    • Lahore, Punjab, Pakistan, 53201
      • Recruiting
      • Major balqees maternity home
      • Contact: Iqra abdul ghafoor, ppdpt; Phone Number: 03216414266; Email: iqra.ghafoor@riphah.edu.pk
      • Sub-Investigator: omaima khan, mswhpt
    • Lahore, Punjab, Pakistan
      • Recruiting
      • Major Balqees Maternity Home Clinic
      • Contact: Iqra abdul ghafoor, ppdpt; Phone Number: 03216414266; Email: iqra.ghafoor@riphah.edu.pk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Age 17-25 years
• Diagnosed cases of dysmenorrhea
• Subject having trigger point in rectus abdominins, quadratus lumborum and gluteus medius
• With regular cycles 21-35 days lasting 3-7 days

Exclusion Criteria:

• Oral contraceptives used for menstrual irregularity
• Other gynecological disease like fibroids, endometriosis
• Who take analgesia
• Endometrial polyp, having pelvic infection using IUD, having venous congestion in internal genital organs.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: group A; Kegel exercises and Myokinetic active release of trigger points

Other: Kegel exercises; It consists of 25 patients who will receive Kegel exercises with Myokinetic active release of trigger points in quadratus lumborum, rectus abdominis and gluteus medius. Patient will be in lying position with empty bladder. Ask patient to tight pelvic floor muscle group and hold tight from 3-5 seconds Then relax muscle group from 3-5 seconds with Myokinetic therapy targeted at releasing muscle of quadratus lumborum, rectus abdominis and gluteus medius release was applied passively by sustained pressure for 8-10 seconds. This protocol consisted of three sets with 2 minutes of rest..Participants will be asked to perform exercise 30 times each session following hold and relax of muscle group for 3-5 seconds; Other Names: myokinetic active release of trigger points; kegel exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
pain is assessed by numerical pain rating scale	11 point numeric pain rating scale	at baseline pre intervention, at the end of 8 week post intervention
FSS scale is used to access fatigue severity	9 items scale	at baseline pre intervention, at the end of 8 week post intervention
SF-36 is used to access quality of life	8 domains with further items	at baseline pre intervention, at the end of 8 week post intervention

Collaborators and Investigators

• Sponsor: Riphah International University
• Investigators: Principal Investigator: Iqra abdul ghafoor, PPDPT, riphah international univrsity

Publications and helpful links

General Publications

• 1. Gupta S, Arora M, Yadav PJRJoMS. Comparative Evaluation of Effectiveness of Pelvic Floor Strengthening and Myokinetic Active Release of Trigger Points in Reducing Dysmenorrhea. 2023;13(3) 2. Rani M, Kaushal K, Kaur S. Prevalence of Musculoskeletal Pain and Awareness of Physiotherapy in Primary Dysmenorrhea among Female Students of Adesh University, Bathinda

Study record dates

Study Major Dates

• Study Start (Actual): December 23, 2023
• Primary Completion (Estimated): February 1, 2025
• Study Completion (Estimated): February 1, 2025

Study Registration Dates

• First Submitted: January 1, 2025
• First Submitted That Met QC Criteria: January 10, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: January 10, 2025
• Last Verified: January 1, 2025

More Information

Terms related to this study

• Keywords: trigger points
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Pathologic Processes; Pelvic Pain; Menstruation Disturbances; Dysmenorrhea
• Other Study ID Numbers: Riphah uni

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No